MissionIR Articles
Original content written and distributed as part of our ongoing relationships.
-
Commtouch Software Ltd. (CTCH) Reports on Exploitative Cybercriminal Activity for its “Security Number of the Month”
When a national or global news story breaks, readers appreciate having a trustworthy news outlet where they can get accurate, up-to-the-minute information. While most news outlets are committed to providing accurate information, it’s becoming increasingly…
-
Enzo Biochem, Inc. (ENZ) Starts Presentation at the Aegis Healthcare Conference
Enzo Biochem, Inc. is an integrated life sciences and biotechnology company that focuses on diagnostic and research products. The company operates in three segments: the Clinical Labs segment offers clinical laboratory tests/procedures used in general…
-
Atossa Genetics, Inc. (ATOS) Starts Presentation at the Aegis Healthcare Conference
Atossa Genetics, Inc. is a healthcare company developing and marketing cellular and molecular diagnostic risk assessment products for breast cancer. The company’s diagnostic tests include the ForeCYTE Breast Health Test, which provides personalized information about…
-
Trovagene Inc. (TROV) Starts Presentation at the Aegis Healthcare Conference
Trovagene Inc. (NASDAQ: TROV) develops diagnostic technologies for use in patient/disease screening and monitoring in various medical disciplines. The company’s urine-based testing platform helps to enhance cancer care management and women’s healthcare. The company’s technology…
-
Aastrom Biosciences, Inc. (ASTM) Starts Presentation at the Aegis Healthcare Conference
Aastrom Biosciences, Inc. develops patient-specific cell products for treating severe, chronic ischemic cardiovascular diseases. The company is developing ixmyelocel-T, a multicellular therapy expanded from a patient’s own bone marrow and delivered directly to damaged tissues.…
-
Cancer Genetics, Inc. (CGIX) Starts Presentation at the Aegis Healthcare Conference
Cancer Genetics, Inc. is an early-stage diagnostics company developing proprietary genomic tests and services to improve and personalize the diagnosis, prognosis, and response to the treatment of cancer. The company’s tests target many cancers, including…
-
Oxygen Biotherapeutics, Inc. (OXBT) Starts Presentation at the Aegis Healthcare Conference
Oxygen Biotherapeutics, Inc. is a development stage company developing biotechnology products that deliver oxygen to target tissues in the body. The company develops Oxycyte, an oxygen carrier for use in situations of acute ischemia, which…
-
Invivo Therapeutics Holdings Corp. (NVIV) Starts Presentation at the Aegis Healthcare Conference
Invivo Therapeutics Holdings Corp. (OTCBB: NVIV) is a development stage company engaged in the development and commercialization of biopolymer scaffolding devices for the treatment of spinal cord injuries, peripheral nerve injuries, and other neurotrauma conditions.…
-
Amarin Corporation plc (AMRN) Starts Presentation at the Aegis Healthcare Conference
Amarin Corporation plc is a biopharmaceutical company engaged in developing and bringing to market therapeutic products for the treatment for cardiovascular diseases. Its product development program areas include lipid science and the therapeutic benefits of…
-
Organovo Holdings, Inc. (ONVO) Starts Presentation at the Aegis Healthcare Conference
Organovo Holdings, Inc. develops three-dimensional (3D) bioprinting technology for creating functional human tissues for research and medical applications. The company’s 3D NovoGen bioprinting technology works across various tissue and cell types, and allows for the…
-
BioSpecifics Technologies Corp. (BSTC) Starts Presentation at the Aegis Healthcare Conference
BioSpecifics Technologies Corp. (NASDAQ: BSTC) is a biopharmaceutical company that is focused on developing an injectable collagenase for various clinical indications. Under the XIAFLEX name, BioSpecifics provides injectable collagenase for the treatment of adult Dupuytren’s…
-
Venaxis, Inc. (APPY) Starts Presentation at the Aegis Healthcare Conference
Venaxis, Inc. develops and commercializes products for unmet diagnostic and therapeutic needs. Its lead product candidate includes APPY1, a blood-based diagnostic test designed to aid in the evaluation of patients for acute appendicitis. The company,…
-
SciClone Pharmaceuticals, Inc. (SCLN) Starts Presentation at the Aegis Healthcare Conference
SciClone Pharmaceuticals, Inc. provides therapies for the treatment of oncology, infectious diseases, cardiovascular, urological, respiratory, and central nervous system disorders in China and internationally. Its principal product is ZADAXIN, which is used for the treatment…
-
Acorda Therapeutics, Inc. (ACOR) Starts Presentation at the Aegis Healthcare Conference
Acorda Therapeutics, Inc. is a commercial-stage biopharmaceutical company that engages in identifying, developing and bringing to market therapies for multiple sclerosis (MS), spinal cord injury and other central nervous system disorders. Acorda’s products include: Ampyra (dalfampridine), a…
-
Advanced Cell Technology, Inc. (ACTC) Starts Presentation at the Aegis Healthcare Conference
Advanced Cell Technology, Inc. is a biotechnology company that develops human embryonic and adult stem cell technology. The company has ownership/licensing of approximately 37 patents and approximately 190 patent applications pending in the regenerative medicine…
-
OxySure Systems, Inc. (OXYS) to Exhibit Innovative Oxygen Technology at the Annual National Safety Council
OxySure Systems, a medical technology company that has pioneered an FDA-approved solution to produce medically pure oxygen from dry, inert powders for emergency and short duration use, will be an exhibitor at the National Safety…
-
Alcobra Ltd. (ADHD) Starts Presentation at the Aegis Healthcare Conference
Alcobra Ltd. is an emerging biopharmaceutical company that develops and markets drugs for the treatment of central nervous system disorders and cognitive dysfunctions. The company is primarily focused on developing and marketing its most advanced…
-
Champions Oncology, Inc. (CSBR) Starts Presentation at the Aegis Healthcare Conference
Champions Oncology, Inc. offers technology solutions that personalize the development and use of oncology drugs. The company’s Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in…
-
Spectrum Pharmaceuticals, Inc. (SPPI) Starts Presentation at the Aegis Healthcare Conference
Spectrum Pharmaceuticals, Inc. is a biotechnology company engaged in acquiring, developing, and marketing prescription drug products for hematology and oncology. The company’s oncology products include FUSILEV for patients with osteosarcoma after high-dose methotrexate therapy; FOLOTYN,…
-
OncoSec Medical Incorporated (ONCS) Starts Presentation at the Aegis Healthcare Conference
OncoSec Medical Incorporated (ONCS) OncoSec Medical Incorporated (OTC: ONCS) designs and develops novel cancer therapeutic products. The company’s products combine proprietary delivery technology with a novel DNA-based immunotherapeutics, known as OMS ElectroOncology. Its clinical programs…
-
Calpian, Inc. (CLPI) Targets Multiple Markets and Revenue Sources
In the U.S., Calpian, among other things, is a leader in a portion of the electronic payments industry known as merchant acquiring. Specifically, Calpian purchases recurring monthly income streams derived from credit card processing fees…
-
Wave Systems Corp. (WAVX) Named a “Visionary” in Gartner’s 2013 Mobile Data Protection Magic Quadrant
Wave Systems, the Trusted Computing Company and foremost expert on building security capabilities directly into endpoint computing platforms themselves, announced today that Gartner Inc. named the company a visionary in its September 2013 Magic Quadrant…
-
Infinity Resources Holdings Corp. (IRHC) Subsidiary Details Economic Benefits of Food Waste Recycling at Arkansas Recycling Coalition
Brian Dick, CEO of Quest Resource Management Group, an Infinity Resources Holdings Corp. company, Tuesday spoke at the Arkansas Recycling Coalition, emphasizing the economic benefits of food waste and discussing the evolution of food waste…
-
Heat Biologics, Inc. (HTBX) Starts Presentation at the Aegis Healthcare Conference
Heat Biologics, Inc. is a biopharmaceutical company developing cellular therapeutic vaccines for cancers and infectious diseases. The company is developing the Immune Pan Antigen Cytotoxic therapy, a platform technology that delivers human cells that are…
-
NeoStem, Inc. (NBS) Starts Presentation at the Aegis Healthcare Conference
NeoStem, Inc. develops proprietary cell therapy products. It is involved in: manufacturing cell therapy-based products; product and process development; cell and tissue processing; regulatory support, storage, distribution and delivery; and consulting services. The company also…
-
PITOOEY!, Inc. (PTOO) Announces Rapid Customer Base Growth
PITOOEY!, a complete digital marketing agency, today announced the ongoing, substantial expansion of its customer base. Choice One Mobile, Inc., a wholly owned subsidiary of the company, has added more than 350 unique customers for…
-
Wheeler Real Estate Investment Trust (WHLR) Expands Tulsa Market Presence with Acquisition of Jenks Reasor’s
Wheeler Real Estate Investment Trust announced it has acquired an 81,000-square-foot freestanding retail property in Jenks, Okla., for approximately $11.4 million, or $140.74 per square foot. The property, Jenks Reasor’s, was acquired through a sale-leaseback…
-
Inovio Pharmaceuticals, Inc. (INO) Starts Presentation at the Aegis Healthcare Conference
Inovio Pharmaceuticals, Inc. (NYSE: INO) and its subsidiaries engage in discovering and developing synthetic vaccines and immune therapies for cancers and other infectious diseases. Inovio’s DNA-based SynCon technology facilitates the design of vaccines capable of…
-
Kips Bay Medical, Inc. (KIPS) Starts Presentation at the Aegis Healthcare Conference
Kips Bay Medical, Inc. (NASDAQ: KIPS) is a medical device company that manufactures its external saphenous vein support technology (eSVS Mesh) for use in coronary artery bypass grafting (CABG) surgery. Its eSVS Mesh is a…
-
VistaGen Therapeutics, Inc. (VSTA) Human Clinical Trials in a Test Tube™ Aims to Revive Failed Small Drug Molecule Candidates
VistaGen has developed a stem cell technology platform based on the controlled transformation of human pluripotent stem cells into mature human cells, which can then be used to create bioassay systems to provide clinically relevant…
-
Jameson Stanford Resources Corp. (JMSN) Initiates Diamond Core Drilling Program
Jameson Stanford Resources, a metals and minerals exploration, development, and production company, announced that it has been managing an extensive third party engineering Diamond Core Drilling Program within the Wild Bill area at the northern…
-
Nanosphere, Inc. (NSPH) Video Chart for Wednesday, September 25, 2013
NSPH is making a move while holding a bottom support around $1.75. The chart is showing a shift happening in trend and momentum, which should have technical traders looking for a possibly slow and steady…
-
Novavax, Inc. (NVAX) Prepares to Initiate Seasonal and Pandemic Influenza Trials with BARDA
Clinical-stage vaccine company Novavax announced that details are being finalized regarding costs and timelines for its next round of clinical studies with the U.S. Department of Health and Human Services, Biomedical Advanced Research, and Development…
-
NTS, Inc. (NTS) Connects First Fiber Customer in Ponchatoula, Louisiana
Yesterday, NTS announced that it has connected its first fiber customer in Ponchatoula, Louisiana. The company has had a presence in Louisiana since April 2013, when it began connecting customers throughout the state. The Louisiana…
-
Chanticleer Holdings, Inc. (HOTR) Carves Out Leading Franchise Presence Domestically and Abroad
Buffalo wings. Orange shorts. Cold Beer. Hooters® has unarguably become one of the nation’s most well-known brands in the casual dining segment of the restaurant industry. Not limited to the male demographic, the restaurant chain…
-
PITOOEY! Inc. (PTOO) Recognizes the Original Promise of Digital Communications
Internet communication and marketing, and its merger with mobile device technology, has been both a blessing and a curse to the consumer. It allows for an information flow unparalleled in human experience, where information of…
-
DreamTeamGroup (DTG) to Provide Comprehensive Social Media Coverage of Aegis Healthcare Conference 2013
DreamTeamGroup (DTG), a consortium of unique marketing brands that utilizes one dynamic approach to connect publicly traded companies with a variety of investors, will provide the investment community with ongoing social media coverage of the…
-
OxySure Systems, Inc. (OXYS) Provides Progress Update on CE Marking
OxySure Systems, a medical technology company that has pioneered an FDA-approved solution to produce medically pure oxygen from dry, inert powders for emergency/short duration use, this morning gave investors a progress report on the CE…
-
NuPathe, Inc. (PATH) Begins Dosing Adolescent Migraine Sufferers in ZECUITY Clinical Study
Specialty pharmaceutical company NuPathe has begun dosing patients for NP101-015, a Phase 1 study of ZECUITY (sumatriptan iontophoretic transdermal system) in adolescents with a history of migraine attacks. An open label, single-dose study, NP101-015 will…
-
On Track Innovations Ltd. (OTIV) Receives Orders from Petroleum Partner for Commercial Quantities of EasyFuel Plus Product
On Track Innovations (“OTI”), a supplier of near field communication and cashless payment solutions worldwide, announced that Tokheim has placed orders for commercial quantities of OTI’s EasyFuel Plus solution. Tokheim is one of the world’s…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Positioned to Power the Future of Clean Energy
- MissionIRNewsBreaks – HeartBeam Inc.’s (NASDAQ: BEAT) IP Momentum Continues with New Patents Advancing 3D ECG Technology
- Silvercorp Metals, Inc. (NYSE-A/TSX: SVM) Reports Solid Production and Revenue in Q1 FY2026
- Clene Inc. (NASDAQ: CLNN) Reports Q2 2025 Results as Company Prepares for NDA Submission and Extends Runway into 2026
- Massimo Group (NASDAQ: MAMO) Accelerates Golf Cart Market Reach with Vietnam Partnership